Metabolic comorbidities are common in patients with cardiorenal disease; they can cause
atherosclerotic cardiovascular disease (ASCVD), speed progression, and adversely affect …

Abstract Purpose of Review To summarize research from the last 5 years on the effects of
weight loss treatments, including lifestyle changes, anti-obesity medications, and bariatric …

Obesity, particularly abdominal adiposity, is increasingly recognized as a cause of elevated
cardiometabolic risk—the risk of developing type 2 diabetes mellitus (DM) and …

The ongoing obesity epidemic represents a global public health crisis that contributes to
poor health outcomes, reduced quality of life, and> 2.8 million deaths each year. Obesity is …

Abstract 'Traditional'risk factors such as hypertension, elevated cholesterol, smoking, and
diabetes have long been linked to cardiovascular disease (CVD). However, although …

Obesity is a serious public health issue with complications that burden healthcare systems
worldwide. While there is abundant evidence for the harmful effects of obesity on …

The metabolic syndrome is a complex constellation of disorders, each one a significant risk
factor for the development of cardiovascular disease (CVD). The increasing prevalence of …

Obesity is an important independent cardiovascular (CV) risk factor and a chronic
inflammatory disease related to the development of insulin resistance, type 2 diabetes …

Cardiovascular disease (CVD) is the leading cause of death in the United States and many
parts of the world. Potentially modifiable risk factors for CVD include tobacco use, physical …

Obesity is a growing public health epidemic worldwide and is implicated in slowing
improved life expectancy and increasing cardiovascular (CV) risk; indeed, several obesity …